MARIMED INC. (MRMD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 15M 30M 45M Q3 '21: 33.2M Q4 '21: 31M Q1 '22: 31.3M Q2 '22: 33M Q3 '22: 33.9M Q4 '22: 35.8M Q1 '23: 34.4M Q2 '23: 36.5M Q3 '23: 38.8M Q4 '23: 38.9M Q1 '24: 37.9M Q2 '24: 40.4M Q3 '24: 40.6M Q4 '24: 38.9M Q1 '25: 37.9M Q2 '25: 39.5M Q3 '25: 40.8M Q4 '25: 41.6M Q1 '26: 39.5M Q2 '26: 41.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 7M 14M 21M Q3 '21: 18.2M Q4 '21: 15.5M Q1 '22: 17M Q2 '22: 15M Q3 '22: 16.2M Q4 '22: 15.8M Q1 '23: 15.4M Q2 '23: 16.4M Q3 '23: 16.8M Q4 '23: 17.3M Q1 '24: 16.5M Q2 '24: 16.9M Q3 '24: 16.8M Q4 '24: 12.7M Q1 '25: 15.1M Q2 '25: 15.9M Q3 '25: 16.4M Q4 '25: 10.5M Q1 '26: 15.3M Q2 '26: 16.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-5M 0 5M 10M 15M Q2 '21: 12M Q3 '21: 6.6M Q4 '21: 1.2M Q1 '22: 7M Q2 '22: 4.5M Q3 '22: 5.7M Q4 '22: 3.1M Q1 '23: 5.1M Q2 '23: 3.5M Q3 '23: 3.3M Q4 '23: 2.4M Q1 '24: 2M Q2 '24: 956K Q3 '24: 1.3M Q1 '25: -910K Q2 '25: 1M Q3 '25: 1.6M Q4 '25: -4.5M Q1 '26: 125K Q2 '26: 418K Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q3 '25 Q2 '26

Net Income Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q2 '21: 7.5M Q3 '21: 2M Q1 '22: 4.2M Q2 '22: 1.8M Q3 '22: 2.7M Q4 '22: 4.8M Q1 '23: -645K Q2 '23: -958K Q3 '23: -4.3M Q4 '23: -10.2M Q1 '24: -1.3M Q2 '24: -1.7M Q3 '24: -1M Q4 '24: -8.3M Q1 '25: -5.5M Q2 '25: -1.4M Q3 '25: -2.9M Q4 '25: -4.6M Q1 '26: -3.8M Q2 '26: -3.6M Q3 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 15M 30M 45M Q3 '21: 15M Q4 '21: 15.6M Q1 '22: 14.3M Q2 '22: 18M Q3 '22: 17.7M Q4 '22: 20M Q1 '23: 19M Q2 '23: 20.1M Q3 '23: 22M Q4 '23: 21.6M Q1 '24: 21.5M Q2 '24: 23.5M Q3 '24: 23.8M Q4 '24: 26.3M Q1 '25: 22.8M Q2 '25: 23.6M Q3 '25: 24.4M Q4 '25: 31.1M Q1 '26: 24.2M Q2 '26: 25.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-8M -4M 0 4M 8M 12M Q2 '21: 10.8M Q3 '21: 10.7M Q4 '21: 7.6M Q1 '22: 8.5M Q2 '22: -6.3M Q3 '22: 3.3M Q4 '22: 1.7M Q1 '23: -4.5M Q2 '23: 1.3M Q3 '23: 7.9M Q4 '23: 3.2M Q1 '24: 3.2M Q2 '24: 3.2M Q3 '24: 803K Q1 '25: 1.3M Q2 '25: 297K Q3 '25: 2.7M Q4 '25: 3.4M Q1 '26: 949K Q2 '26: 2.2M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q2 '21: 5.2M Q3 '21: 4M Q4 '21: 4.4M Q1 '22: 4.5M Q2 '22: -10.1M Q3 '22: 1.2M Q4 '22: -418K Q1 '23: -7.6M Q2 '23: -4.5M Q3 '23: 1.9M Q4 '23: -2.1M Q1 '24: -158K Q2 '24: -1.8M Q3 '24: -1.8M Q1 '25: 1M Q2 '25: -12K Q3 '25: 2.1M Q4 '25: 3.4M Q1 '26: 576K Q2 '26: 1.9M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q1 '20: 230.8M Q2 '20: 248M Q3 '20: 346.1M Q1 '21: 340.8M Q2 '21: 370.3M Q3 '21: 378.9M Q1 '22: 378.9M Q2 '22: 379.6M Q3 '22: 381.1M Q1 '23: 342.8M Q2 '23: 361.3M Q3 '23: 373.1M Q1 '24: 375.2M Q2 '24: 379.5M Q3 '24: 380.6M Q1 '25: 382.6M Q2 '25: 389.9M Q3 '25: 392.6M Q1 '26: 397.4M Q2 '26: 399.6M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.45 -0.30 -0.15 0.00 0.15 0.30 0.45 Q3 '20: -0.39 Q4 '20: 0.01 Q1 '21: 0.03 Q2 '21: 0.05 Q3 '21: 0.06 Q4 '22: 0.04 Q1 '23: 0.03 Q2 '23: 0.03 Q3 '23: 0.01 Q4 '23: -0.03 Q1 '24: -0.03 Q2 '24: -0.03 Q3 '24: -0.02 Q4 '24: -0.02 Q1 '25: -0.03 Q2 '25: -0.03 Q3 '25: -0.04 Q4 '25: -0.03 Q1 '26: -0.03 Q2 '26: -0.04 Q4 '20 Q3 '21 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.